Ywhaz-flox Mouse
Common Name
Ywhaz-flox
제품 ID
S-CKO-06925
Backgroud
C57BL/6JCya
품종 계통계통 ID
CKOCMP-22631-Ywhaz-B6J-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Ywhaz-flox Mouse (카탈로그 번호 S-CKO-06925)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Ywhaz-flox
품종 계통계통 ID
CKOCMP-22631-Ywhaz-B6J-VA
유전자명
제품 ID
S-CKO-06925
유전자 별칭
14-3-3zeta, 1110013I11Rik
배경
C57BL/6JCya
NCBI ID
변형 내용
Conditional knockout
염색체
Chr 15
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000022894
NCBI 전사체 ID
NM_011740
타겟 영역
Exon 4
유효 영역 크기
~0.6 kb
유전자 연구 개요
YWHAZ, also named 14-3-3ζ, is a central hub protein involved in many signal transduction pathways. It plays a significant role in controlling cellular proliferation, migration, and differentiation. YWHAZ is associated with pathways like PI3K-Akt-mTOR, and influences vital cellular processes such as metabolism, apoptosis, and cell cycle regulation [1,2,3].
In cancer research, YWHAZ is frequently up-regulated in multiple cancer types. In gastric cancer, TMEM65 promotes tumorigenesis by targeting YWHAZ to activate the PI3K-Akt-mTOR pathway [2]. In ovarian cancer, YWHAZ promotes metastasis by modulating glycolysis, and its silencing inhibits cell proliferation, migration, and in vivo metastasis [3]. In breast cancer, YWHAZ interacts with DAAM1 to promote cell migration [4]. In bladder cancer, YWHAZ amplification/overexpression defines aggressive cancer and contributes to chemo -/radio-resistance by suppressing caspase-mediated apoptosis [5]. In gastric cancer, knockdown of YWHAZ inhibits cell migration, invasion, and EMT, and restrains the activation of the wnt/β-catenin signalling pathway [6]. In non-small cell lung cancer, miR-3074-5p suppresses cancer progression by targeting the YWHAZ/Hsp27 axis [7]. In hepatocellular carcinoma, wogonin inhibits cell proliferation by targeting the miR-27b-5p/YWHAZ axis [8].
In conclusion, YWHAZ plays crucial roles in various biological processes, especially in cancer progression. Studies on YWHAZ in different cancer models help to understand its functions in promoting tumorigenesis, metastasis, and resistance to treatment, providing potential therapeutic targets for cancer treatment.
References:
1. Gan, Yun, Ye, Feng, He, Xing-Xing. 2020. The role of YWHAZ in cancer: A maze of opportunities and challenges. In Journal of Cancer, 11, 2252-2264. doi:10.7150/jca.41316. https://pubmed.ncbi.nlm.nih.gov/32127952/
2. Shi, Lingxue, Wang, Xiaohong, Guo, Shang, Yu, Weifang, Yu, Jun. 2024. TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate PI3K-Akt-mTOR pathway and is a therapeutic target. In Oncogene, 43, 931-943. doi:10.1038/s41388-024-02959-9. https://pubmed.ncbi.nlm.nih.gov/38341472/
3. Shi, Jie, Ye, Jun, Fei, He, Zhang, Li-Wen, Yang, Xiao-Mei. 2018. YWHAZ promotes ovarian cancer metastasis by modulating glycolysis. In Oncology reports, 41, 1101-1112. doi:10.3892/or.2018.6920. https://pubmed.ncbi.nlm.nih.gov/30535456/
4. Mei, Jie, Liu, Yan, Yu, Xinqian, Zhang, Yan, Zhu, Yichao. 2021. YWHAZ interacts with DAAM1 to promote cell migration in breast cancer. In Cell death discovery, 7, 221. doi:10.1038/s41420-021-00609-7. https://pubmed.ncbi.nlm.nih.gov/34453038/
5. Yu, Chia-Cheng, Li, Chien-Feng, Chen, I-Hsuan, Lee, Shan-Chih, Sheu, Jim J-C. 2019. YWHAZ amplification/overexpression defines aggressive bladder cancer and contributes to chemo-/radio-resistance by suppressing caspase-mediated apoptosis. In The Journal of pathology, 248, 476-487. doi:10.1002/path.5274. https://pubmed.ncbi.nlm.nih.gov/30945298/
6. Guo, Feng, Gao, Yongjian, Sui, Guoqing, Fu, Qingfeng, Jin, Chunxiang. 2018. miR-375-3p/YWHAZ/β-catenin axis regulates migration, invasion, EMT in gastric cancer cells. In Clinical and experimental pharmacology & physiology, 46, 144-152. doi:10.1111/1440-1681.13047. https://pubmed.ncbi.nlm.nih.gov/30353914/
7. Dong, Nian, Gu, Wen-Wen, Yang, Long, Chen, Cheng-Shui, Wang, Bei-Bei. 2024. MiR-3074-5p suppresses non-small cell lung cancer progression by targeting the YWHAZ/Hsp27 axis. In International immunopharmacology, 138, 112547. doi:10.1016/j.intimp.2024.112547. https://pubmed.ncbi.nlm.nih.gov/38943969/
8. Ma, Ming-Yue, Wang, Qian, Wang, Shou-Mei, Xian, Zhi-Hong, Zhang, Shu-Hui. 2023. Wogonin inhibits hepatoma cell proliferation by targeting miR-27b-5p/YWHAZ axis. In Journal of biochemical and molecular toxicology, 37, e23508. doi:10.1002/jbt.23508. https://pubmed.ncbi.nlm.nih.gov/37623816/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
